Kim Sablich Insider Trading $MYOV Myovant Sciences Ltd.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kim Sablich.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kim Sablich. Kim Sablich is EVP & GM, North America in Jazz Pharmaceuticals plc ($JAZZ) and Director in Eiger BioPharmaceuticals, Inc. ($EIGR) and Chief Commercial Officer in Myovant Sciences Ltd. ($MYOV).
Kim Sablich in Myovant Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kim Sablich: Chief Commercial Officer
Holdings: 146,710 shares
Current Value: $1,565,396
Latest Transaction: Apr 07 2020
$MYOV Market Capitalization: $630.81M
$MYOV Previous Close: $10.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Kim Sablich in Myovant Sciences Ltd.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EIGR, JAZZ, MYOV
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | A | 8.08 | 134,464 | 1,086,469 | 134,464 | |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Grant | A | 0.00 | 87,805 | 0 | 146,710 | 58.9 K to 146.7 K (+149.06 %) |
| Mar 19 2020 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Sell | S | 6.93 | 15 | 104 | 58,905 | 58.9 K to 58.9 K (-0.03 %) |
| Mar 19 2020 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Sell | S | 7.38 | 770 | 5,683 | 58,920 | 59.7 K to 58.9 K (-1.29 %) |
| Jan 16 2020 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Sell | S | 14.04 | 4,840 | 67,954 | 59,690 | 64.5 K to 59.7 K (-7.50 %) |
| Dec 19 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Sell | S | 16.22 | 2,585 | 41,929 | 64,530 | 67.1 K to 64.5 K (-3.85 %) |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | A | 7.78 | 66,130 | 514,491 | 66,130 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | D | 24.44 | 66,130 | 1,616,217 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | A | 7.78 | 133,500 | 1,038,630 | 133,500 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | D | 17.28 | 133,500 | 2,306,880 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Grant | A | 0.00 | 37,415 | 0 | 67,115 | 29.7 K to 67.1 K (+125.98 %) |
| Apr 09 2019 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | A | 24.44 | 66,130 | 1,616,217 | 66,130 | |
| Dec 18 2018 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | A | 17.28 | 133,500 | 2,306,880 | 133,500 | |
| Dec 18 2018 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Grant | A | 0.00 | 29,700 | 0 | 29,700 | 0 to 29.7 K |
Page: 1